Literature DB >> 9285466

Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation.

C Tranchant1, N Sergeant, A Wattez, M Mohr, J M Warter, A Delacourte.   

Abstract

One patient of a French family with Gerstmann-Sträussler-Scheinker syndrome with the mutation in codon 117 of the prion protein (PrP) gene displayed unexpected neuritic degeneration around PrP plaques and numerous diffuse neurofibrillary tangles, whereas other members did not. The tau profile in this patient's brain was analysed and compared with one from another member of the Gerstmann-Sträussler-Scheinker family as well as with the Alzheimer's tau profile. A panel of well characterised antibodies against both normal tau protein and paired helical filaments-tau protein was used on immunoblots of brain proteins resolved by mono and two dimensional gels. The tau profile in the patient with Gerstmann-Sträussler-Scheinker syndrome without neurofibrillary tangles was normal. The tau profile from the patient with Gerstmann-Sträussler-Scheinker syndrome and neurofibrillary tangles was characterised by a hyperaggregation state of tau protein. This case illustrates the phenotypic heterogeneity of the GSS117 mutation not only from one family to another, but also between members of the same family. In this family, the presence of neurofibrillary tangles is still unexplained, but could be correlated with either the protracted duration of the disease or the old age of the patient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285466      PMCID: PMC2169673          DOI: 10.1136/jnnp.63.2.240

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Computational studies on prion proteins: effect of Ala(117)-->Val mutation.

Authors:  Noriaki Okimoto; Kazunori Yamanaka; Atsushi Suenaga; Masayuki Hata; Tyuji Hoshino
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

2.  Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Authors:  Fumiko Furukawa; Nobuo Sanjo; Atsushi Kobayashi; Tsuyoshi Hamaguchi; Masahito Yamada; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Takanori Yokota
Journal:  Prion       Date:  2018-11-13       Impact factor: 3.931

3.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

4.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.

Authors:  D R Brown
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 6.  Molecular advances in understanding inherited prion diseases.

Authors:  David R Brown
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

7.  Genotype patterns and characteristics of PRNP in the Korean population.

Authors:  Sol Moe Lee; Young Ran Ju; Bo-Yeong Choi; Jae Wook Hyeon; Jun Sun Park; Chi Kyeong Kim; Su Yeon Kim
Journal:  Prion       Date:  2012-05-07       Impact factor: 3.931

8.  Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies.

Authors:  Vıctor Manuel Gómez-López; Amparo Viramontes-Pintos; Miguel Ángel Ontiveros-Torres; Linda Garcés-Ramírez; Fidel de la Cruz; Ignacio Villanueva-Fierro; Marely Bravo-Muñoz; Charles R Harrington; Sandra Martínez-Robles; Petra Yescas; Parménides Guadarrama-Ortíz; Mario Hernandes-Alejandro; Francisco Montiel-Sosa; Mar Pacheco-Herrero; José Luna-Muñoz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Authors:  Lulu Ning; Dabo Pan; Yan Zhang; Shaopeng Wang; Huanxiang Liu; Xiaojun Yao
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

10.  Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.

Authors:  Lilla Reiniger; Ilaria Mirabile; Ana Lukic; Jonathan Df Wadsworth; Jacqueline M Linehan; Michael Groves; Jessica Lowe; Ronald Druyeh; Peter Rudge; John Collinge; Simon Mead; Sebastian Brandner
Journal:  Acta Neuropathol Commun       Date:  2013-05-09       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.